PMC:7299399 / 31017-31290 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7299399","sourcedb":"PMC","sourceid":"7299399","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7299399","text":"In addition, specific nanotools can be designed to evade the immune system and to enhance the solubility of poorly soluble immunosuppressant agents; the potential of finely tuning their surface charge opens possibilities for encapsulation strategies and offers accommodatio","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T138","span":{"begin":61,"end":74},"obj":"Body_part"}],"attributes":[{"id":"A138","pred":"fma_id","subj":"T138","obj":"http://purl.org/sig/ont/fma/fma9825"},{"subj":"T138","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T32","span":{"begin":61,"end":74},"obj":"Body_part"}],"attributes":[{"id":"A32","pred":"uberon_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"subj":"T32","pred":"source","obj":"LitCovid-PD-UBERON"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T284","span":{"begin":61,"end":74},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"}],"attributes":[{"subj":"T284","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T231","span":{"begin":123,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A231","pred":"chebi_id","subj":"T231","obj":"http://purl.obolibrary.org/obo/CHEBI_35705"},{"subj":"T231","pred":"source","obj":"LitCovid-PD-CHEBI"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#93bdec","default":true},{"id":"LitCovid-PD-UBERON","color":"#d7ec93"},{"id":"LitCovid-PD-CLO","color":"#e793ec"},{"id":"LitCovid-PD-CHEBI","color":"#93eccd"}]}]}}